Takeda Pharmaceutical Co. , Asia’s largest drugmaker, is seeking a 10-fold revenue gain in China within five years after hiring a top executive to stem an exodus of sales employees there, President Yasuchika Hasegawa said.
Takeda Pharmaceutical Co., Asia’s biggest drugmaker, named GlaxoSmithKline Plc’s Christophe Weber as the leading candidate to become its next chief executive officer in a bid to capitalize on the Japanese company’s growing global network.
Takeda Pharmaceutical Co. President Yasuchika Hasegawa spent four years searching for an acquisition in Europe to revive growth. The result: Nycomed, a Swiss drugmaker with falling earnings and a $9.1 billion price tag.
Prime Minister Shinzo Abe said the deflation that wiped out much of Japan’s growth the past 15 years and so stunted the economy that it slipped to No. 3 behind China, has ended and will be thwarted by new government policies designed to encourage business expansion.